These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9508364)

  • 1. Comparative studies of MCL-5 cells and human lymphocytes for detecting indirect-acting clastogens.
    Yamakage K; Kusakabe H; Tanaka N
    Mutat Res; 1998 Jan; 412(1):55-61. PubMed ID: 9508364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase.
    Crofton-Sleigh C; Doherty A; Ellard S; Parry EM; Venitt S
    Mutagenesis; 1993 Jul; 8(4):363-72. PubMed ID: 8377657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of chromosome aberrations and sister chromatid exchange by indirectly acting mutagens in immortal mouse and rat hepatocyte lines.
    Salassidis K; Kulka U; Schmid E; Paul D; Bauchinger M
    Mutagenesis; 1991 Jan; 6(1):59-63. PubMed ID: 1903829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.
    Styles JA; Davies A; Lim CK; De Matteis F; Stanley LA; White IN; Yuan ZX; Smith LL
    Carcinogenesis; 1994 Jan; 15(1):5-9. PubMed ID: 8293548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing.
    Crespi CL; Gonzalez FJ; Steimel DT; Turner TR; Gelboin HV; Penman BW; Langenbach R
    Chem Res Toxicol; 1991; 4(5):566-72. PubMed ID: 1793807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines.
    Lampen A; Bader A; Bestmann T; Winkler M; Witte L; Borlak JT
    Xenobiotica; 1998 May; 28(5):429-41. PubMed ID: 9622846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
    Johnson TE; Umbenhauer DR; Galloway SM
    Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic effects of promutagens in genetically engineered V79 Chinese hamster cells expressing cytochromes P450.
    Kulka U; Doehmer J; Glatt HR; Bauchinger M
    Eur J Pharmacol; 1993 Apr; 228(5-6):299-304. PubMed ID: 8482321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
    Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV
    Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of comparative genomic hybridization and fluorescence in situ hybridization to the characterization of genotoxicity screening tester strains AHH-1 and MCL-5.
    Corso C; Parry EM
    Mutagenesis; 1999 Jul; 14(4):417-26. PubMed ID: 10390510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin B1, 2-aminoanthracene, and 7,12-dimethylbenz[a]anthracene-induced frameshift mutations in human APRT.
    Zhu Y; Bye S; Stambrook PJ; Tischfield JA
    Environ Mol Mutagen; 1995; 26(3):234-9. PubMed ID: 7588649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Sadrieh N; Snyderwine EG
    Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cell mutagenicity of mono- and dinitropyrenes in metabolically competent MCL-5 cells.
    Busby WF; Penman BW; Crespi CL
    Mutat Res; 1994 Oct; 322(4):233-42. PubMed ID: 7523917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphocytes assay: cyclophosphamide metabolic activation by S9 system with low cytotoxicity.
    Sbrana I; Zaccaro L; Lascialfari D; Ceccherini I; Loprieno N
    Mutat Res; 1984 Dec; 130(6):411-6. PubMed ID: 6513968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of short-term mutagenicity test systems in vitro: metabolic activation of indirectly acting mutagens by three immortal rat hepatocyte lines.
    Kulka U; Paul D; Bauchinger M
    Mutagenesis; 1993 May; 8(3):193-7. PubMed ID: 8332081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.
    Penman BW; Chen L; Gelboin HV; Gonzalez FJ; Crespi CL
    Carcinogenesis; 1994 Sep; 15(9):1931-7. PubMed ID: 7923587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.